Citigroup Inc Omega Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 31 shares of OMGA stock, worth $23. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 9,572 99.68%

Holding current value

$23

Previous $19,000 100.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.22 - $2.25 $11,640 - $21,467	-9,541 Reduced 99.68%	31 $0
Q2 2024 Aug 12, 2024	SELL	$1.86 - $3.2 $873,264 - $1.5 Million	-469,497 Reduced 98.0%	9,572 $19,000
Q1 2024 May 10, 2024	BUY	$2.73 - $5.32 $999 - $1,947	366 Added 0.08%	479,069 $1.75 Million
Q4 2023 Feb 09, 2024	BUY	$1.35 - $3.21 $645,306 - $1.53 Million	478,005 Added 68482.09%	478,703 $1.44 Million
Q3 2023 Nov 09, 2023	SELL	$2.15 - $5.68 $105,803 - $279,518	-49,211 Reduced 98.6%	698 $1,000
Q2 2023 Aug 10, 2023	SELL	$5.6 - $9.66 $36,876 - $63,611	-6,585 Reduced 11.66%	49,909 $279,000
Q1 2023 May 11, 2023	BUY	$4.81 - $10.95 $110,389 - $251,302	22,950 Added 68.42%	56,494 $340,000
Q4 2022 Feb 09, 2023	BUY	$4.22 - $7.05 $125,979 - $210,463	29,853 Added 808.81%	33,544 $191,000
Q3 2022 Nov 10, 2022	BUY	$3.63 - $6.65 $9,906 - $18,147	2,729 Added 283.68%	3,691 $20,000
Q2 2022 Aug 10, 2022	SELL	$2.01 - $7.19 $3,336 - $11,935	-1,660 Reduced 63.31%	962 $4,000
Q1 2022 May 12, 2022	SELL	$6.24 - $14.04 $4,736 - $10,656	-759 Reduced 22.45%	2,622 $16,000
Q4 2021 Feb 10, 2022	BUY	$11.33 - $29.38 $28,834 - $74,772	2,545 Added 304.43%	3,381 $38,000
Q3 2021 Nov 10, 2021	BUY	$16.0 - $22.51 $13,376 - $18,818	836 New	836 $16,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.4M

Call Options Held

25.8K

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $35.9M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account